Use of tumor necrosis factor inhibitors in rheumatoid arthritis: a national survey of practicing United States rheumatologists
- 1 December 2006
- journal article
- Published by Elsevier BV in Joint Bone Spine
- Vol. 73 (6), 718-724
- https://doi.org/10.1016/j.jbspin.2006.05.002
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Does safety make a difference in selecting the right TNF antagonist?Arthritis Research & Therapy, 2004
- Direct medical costs and their predictors in patients with rheumatoid arthritisArthritis & Rheumatism, 2003
- Monitoring by rheumatologists for methotrexate-, etanercept-, infliximab-, and anakinra-associated adverse eventsArthritis & Rheumatism, 2003
- Use of Biologics for Rheumatoid Arthritis Tempered by Concerns Over Safety, CostJAMA, 2003
- Biological response modifiers in the management of rheumatoid arthritis.American Journal of Health-System Pharmacy, 2003
- Guidelines for the management of rheumatoid arthritis: 2002 UpdateArthritis & Rheumatism, 2002
- THE EPIDEMIOLOGY OF RHEUMATOID ARTHRITISRheumatic Disease Clinics of North America, 2001
- Rational Use of New and Existing Disease-Modifying Agents in Rheumatoid ArthritisAnnals of Internal Medicine, 2001
- Patterns of disease-modifying antirheumatic drug use, medical resource consumption, and cost among rheumatoid arthritis patients.Therapeutic Apheresis and Dialysis, 2001
- The costs of rheumatoid arthritis: an international long-term viewSeminars in Arthritis and Rheumatism, 2000